[SYRS] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
15-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -5.02%
YoY- -8.76%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
Revenue 4,827 2,379 454 370 1,101 0 0 -
PBT -14,228 -17,226 -16,461 -14,463 -11,515 -10,588 -4,568 20.82%
Tax 967 0 0 0 0 0 0 -
NP -14,228 -17,226 -16,461 -14,463 -11,515 -10,588 -4,568 20.82%
Tax Rate - - - - - - - -
Total Cost 19,055 19,605 16,915 14,833 12,616 10,588 4,568 26.84%
Ratio Analysis
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
NP Margin -294.76 -724.09 -3,625.77 -3,908.92 -1,045.87 0.00 0.00 -
Per Share
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
EPS -2.32 -3.92 -4.87 -4.77 -4.92 -4.65 -2.55 -1.56%
EPS Diluted -2.32 -3.92 -4.87 -4.77 -4.92 -4.65 -2.55 -1.56%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.